These studies thus provided support for PSMD9 as a bona fide regulator of lipid metabolism in mice and humans and suggested that this protein could be a potential target of interest for clinical obesity and hepatosteatosis. Here, PSMD9 is linked to obesity due to melanocortin 4 receptor deficiency.